GSA Capital Partners’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Sell |
27,051
-13,408
| -33% | -$683K | 0.1% | 273 |
|
|
2025
Q1 | $1.82M | Sell |
40,459
-13,664
| -25% | -$616K | 0.16% | 89 |
|
|
2024
Q4 | $2.24M | Sell |
54,123
-3,862
| -7% | -$160K | 0.17% | 63 |
|
|
2024
Q3 | $2.26M | Buy |
57,985
+51,482
| +792% | +$2.01M | 0.17% | 88 |
|
|
2024
Q2 | $222K | Buy |
+6,503
| New | +$222K | 0.02% | 1423 |
|
|
2022
Q2 | – | Sell |
-14,869
| Closed | -$327K | – | 1649 |
|
|
2022
Q1 | $327K | Sell |
14,869
-8,232
| -36% | -$181K | 0.04% | 833 |
|
|
2021
Q4 | $368K | Sell |
23,101
-16,607
| -42% | -$265K | 0.05% | 799 |
|
|
2021
Q3 | $791K | Buy |
39,708
+8,193
| +26% | +$163K | 0.08% | 429 |
|
|
2021
Q2 | $545K | Sell |
31,515
-3,344
| -10% | -$57.8K | 0.06% | 569 |
|
|
2021
Q1 | $691K | Buy |
34,859
+13,150
| +61% | +$261K | 0.11% | 212 |
|
|
2020
Q4 | $379K | Buy |
+21,709
| New | +$379K | 0.06% | 608 |
|